IP Library Granted Patent US 9,066,953
Granted Patent B2
US 9,066,953 · App. 13/623,118 · Granted Jun 30, 2015

Methods for increasing endurance and fat metabolism in humans

Inventors: Amy L. Heaton (Salt Lake City, UT); Mitchell K. Friedlander (Salt Lake City, UT); Dennis Gay (Salt Lake City, UT)
Assignee: QUALITY IP HOLDINGS, LLC
A61K36/538A61K31/4015A61K31/198A61K9/0053A61K31/401A23L1/3051A23V2002/00A61K9/48
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,066,953
App. No.
13/623,118
Granted
Jun 30, 2015
Kind
B2
Abstract

Embodiments of the invention generally relate to methods and supplements for increasing endurance and fat metabolism in human beings.

Claims (18)

1. A method of increasing endurance and fat metabolism in human beings, comprising:

providing an oral nutritional supplement, comprising:

1-arginine hydrochloride;

oxo-proline;

1-lysine hydrochloride; and

n-acetyl-1-cysteine, 1-glutamine, or both;

wherein the L-arginine hydrochloride is present in an amount from 0.1 to 6 mmol, the oxo-proline is present in an amount from 0.1 to 8 mmol, and the L-lysine hydrochloride is present in an amount from 0.1 to 12 mmol; and

orally administering the nutritional supplement to a human being to increase endurance and fat metabolism.

2. The method of claim 1 , wherein the L-arginine hydrochloride is present in an amount from 2.5 to 4.5 mmol, the oxo-proline is present in an amount from 4 to 6 mmol, and the L-lysine hydrochloride is present in an amount from 7 to 9 mmol.

3. The method of claim 1 , wherein n-acetyl L-cysteine or 1-glutamine are present in an amount from 0.001 to 0.5 mmol.

4. The method of claim 1 , wherein the nutritional supplement is present in an amount of 2.9 grams.

5. The method of claim 1 , wherein the nutritional supplement is in powder, tablet, capsule, liquid, or wafer form.

6. The method of claim 1 , wherein the nutritional supplement is administered from one to three times daily.

7. The method of claim 1 , wherein the nutritional supplement is administered once a week.

8. The method of claim 1 , wherein the nutritional supplement is administered on an empty stomach.

9. The method of claim 1 , further comprising L-glutamine.

10. The method of claim 1 , further comprising schizonepeta powder.

11. The method of claim 1 , wherein orally administering the nutritional supplement to a human being comprises orally administering the nutritional supplement to a human that is at least 30 years old.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jan 5, 2023
From: CASPAR CAPITAL LP
To: QUALITY IP HOLDINGS LLC
Reel/Frame 062283/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2022
From: CERBERUS BUSINESS FINANCE, LLC
To: CASPAR CAPITAL LP
Reel/Frame 061636/0625 →
ASSIGNMENT OF SECURITY INTEREST Recorded Dec 30, 2019
From: LS2, LLC
To: CERBERUS BUSINESS FINANCE, LLC
Reel/Frame 051447/0114 →
SECURITY INTEREST Recorded Aug 21, 2015
From: QUALITY IP HOLDINGS, LLC
To: LS2, LLC
Reel/Frame 036392/0053 →
ASSIGNMENT FOR SECURITY - PATENTS Recorded Dec 4, 2014
From: QUALITY IP HOLDINGS, LLC
To: CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 034535/0294 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2014
From: HEATON, AMY L.; FRIEDLANDER, MITCHELL K.; GAY, DENNIS
To: QUALITY IP HOLDINGS, LLC
Reel/Frame 033328/0900 →
Continuity (1)
Related Publication 20140080888A1 · Mar 20, 2014